A detailed history of Fernwood Investment Management, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Fernwood Investment Management, LLC holds 9,681 shares of NRIX stock, worth $191,974. This represents 0.07% of its overall portfolio holdings.

Number of Shares
9,681
Previous 9,681 -0.0%
Holding current value
$191,974
Previous $202,000 7.43%
% of portfolio
0.07%
Previous 0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$7.77 - $15.66 $75,221 - $151,604
9,681 New
9,681 $142,000

Others Institutions Holding NRIX

About Nurix Therapeutics, Inc.


  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $935M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Fernwood Investment Management, LLC Portfolio

Follow Fernwood Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fernwood Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fernwood Investment Management, LLC with notifications on news.